Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: US Preventive Services Task Force Recommendation Statement

被引:232
作者
Siu, Albert L. [1 ]
机构
[1] US Prevent Serv Task Force, Rockville, MD USA
关键词
IMPAIRED FASTING GLUCOSE; LIFE-STYLE INTERVENTION; ALL-CAUSE MORTALITY; LOW-DOSE ASPIRIN; FOLLOW-UP; CARDIOVASCULAR OUTCOMES; PRESSURE CONTROL; ADDITION-EUROPE; PEOPLE; TOLERANCE;
D O I
10.7326/M15-2345
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Description: Update of the 2008 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for diabetes in asymptomatic adults. Methods: The USPSTF reviewed the evidence on screening for impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes in asymptomatic, nonpregnant adults who are at average or high risk for diabetes and its complications. Population: This recommendation applies to adults aged 40 to 70 years seen in primary care settings who do not have symptoms of diabetes and are overweight or obese. Recommendation: The USPSTF recommends screening for abnormal blood glucose as part of cardiovascular risk assessment in adults aged 40 to 70 years who are overweight or obese. Clinicians should offer or refer patients with abnormal blood glucose to intensive behavioral counseling interventions to promote a healthful diet and physical activity. (B recommendation)
引用
收藏
页码:861 / +
页数:9
相关论文
共 51 条
  • [1] American Academy of Family Physicians, 2008, CLIN PREV SERV REC D
  • [2] Introduction
    不详
    [J]. DIABETES CARE, 2015, 38 : S1 - S2
  • [3] [Anonymous], 2009, National Evidence Based Guideline for Blood Glucose Control in Type 2 Diabetes
  • [4] [Anonymous], 2014, National diabetes statistics report
  • [5] Long-term multiple risk factor interventions in Japanese elderly diabetic patients: The Japanese Elderly Diabetes Intervention Trial - study design, baseline characteristics and effects of intervention
    Araki, Atsushi
    Iimuro, Satoshi
    Sakurai, Takashi
    Umegaki, Hiroyuki
    Iijima, Katsuya
    Nakano, Hiroshi
    Oba, Kenzo
    Yokono, Koichi
    Sone, Hirohito
    Yamada, Nobuhiro
    Ako, Junya
    Kozaki, Koichi
    Miura, Hisayuki
    Kashiwagi, Atsunori
    Kikkawa, Ryuichi
    Yoshimura, Yukio
    Nakano, Tadasumi
    Ohashi, Yasuo
    Ito, Hideki
    [J]. GERIATRICS & GERONTOLOGY INTERNATIONAL, 2012, 12 : 7 - 17
  • [6] Blood Pressure Targets in Subjects With Type 2 Diabetes Mellitus/Impaired Fasting Glucose Observations From Traditional and Bayesian Random-Effects Meta-Analyses of Randomized Trials
    Bangalore, Sripal
    Kumar, Sunil
    Lobach, Iryna
    Messerli, Franz H.
    [J]. CIRCULATION, 2011, 123 (24) : 2799 - +
  • [7] Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials
    Boussageon, Remy
    Bejan-Angoulvant, Theodora
    Saadatian-Elahi, Mitra
    Lafont, Sandrine
    Bergeonneau, Claire
    Kassai, Behrouz
    Erpeldinger, Sylvie
    Wright, James M.
    Gueyffier, Francois
    Cornu, Catherine
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2011, 343
  • [8] Long-Term Safety, Tolerability, and Weight Loss Associated With Metformin in the Diabetes Prevention Program Outcomes Study
    Bray, George A.
    Edelstein, Sharon L.
    Crandall, Jill P.
    Aroda, Vanita R.
    Franks, Paul W.
    Fujimoto, Wilfred
    Horton, Edward
    Jeffries, Susan
    Montez, Maria
    Mudaliar, Sunder
    Pi-Sunyer, F. Xavier
    White, Neil H.
    Knowler, William C.
    [J]. DIABETES CARE, 2012, 35 (04) : 731 - 737
  • [9] Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
    Cushman, William C.
    Evans, Gregory W.
    Byington, Robert P.
    Goff, David C., Jr.
    Grimm, Richard H., Jr.
    Cutler, Jeffrey A.
    Simons-Morton, Denise G.
    Basile, Jan N.
    Corson, Marshall A.
    Probstfield, Jeffrey L.
    Katz, Lois
    Peterson, Kevin A.
    Friedewald, William T.
    Buse, John B.
    Bigger, J. Thomas
    Gerstein, Hertzel C.
    Ismail-Beigi, Faramarz
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (17) : 1575 - 1585
  • [10] Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose - Results of the Diabetes Reduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial
    Dagenais, G. R.
    Gerstein, H. C.
    Holman, R.
    Budaj, A.
    Escalante, A.
    Hedner, T.
    Keltai, M.
    Lonn, E.
    McFarlane, S.
    McQueen, M.
    Teo, K.
    Sheridan, P.
    Bosch, J.
    Pogue, J.
    Yusuf, S.
    [J]. DIABETES CARE, 2008, 31 (05) : 1007 - 1014